Imagine a world where heavy periods, excessive bleeding after dental work, or prolonged nosebleeds aren't just inconveniences, but signs of a hidden, inherited disorder. In Ireland, groundbreaking research is changing the way we understand and treat these conditions, particularly in women, and its impact is rippling across the globe.
Dr. Michelle Lavin, a consultant haematologist and researcher at the Royal College of Surgeons in Ireland (RCSI) and St. James's Hospital, is at the forefront of this work. Her focus? Inherited bleeding disorders. These disorders, encompassing well-known conditions like haemophilia and the often-overlooked von Willebrand disease, share a common thread: they disrupt the body's natural ability to stop bleeding, leading to potentially serious health complications.
But here's where it gets controversial... While bleeding disorders affect both men and women, Dr. Lavin's research shines a light on a critical gap in diagnosis and treatment specifically for women. Why is this the case? A significant factor is menstruation. For women with underlying bleeding disorders, periods can become debilitating, characterized by excessively heavy flow that significantly impacts their quality of life. Think soaking through multiple pads daily, prolonged bleeding lasting over seven days, and frequent absences from work or school. Furthermore, the risk of severe bleeding during childbirth is significantly elevated in women with undiagnosed and unmanaged bleeding disorders. Therefore, early and accurate diagnosis is absolutely vital.
So, what can be done to alleviate these challenges? For conditions like haemophilia and von Willebrand disease, the solution often lies in replacing the missing or malfunctioning clotting factors – the very components that help the body form blood clots and stop bleeding. By providing these clotting factors through medication, doctors can effectively control and prevent excessive bleeding episodes. Hormone-based therapies, such as the contraceptive pill, can also play a crucial role in managing monthly menstrual bleeding and reducing its severity. It’s a multi-pronged approach tailored to individual needs.
Dr. Lavin expertly juggles her clinical responsibilities at St. James's Hospital with her research endeavors at RCSI. How does she manage this demanding balancing act? She emphasizes the crucial synergy between the two roles. "You need to set aside time for research as it helps improve clinical care," she explains. Her clinical experience informs her research questions, while her research findings directly translate into improved patient care. By strategically allocating her time and reducing her clinical hours, she dedicates herself to research, grant writing, publishing papers, and conducting crucial studies. This dedication also allows her to share Irish research findings with international networks, particularly within Europe, fostering collaboration and knowledge exchange.
The aspect of her research that Dr. Lavin finds most rewarding is its tangible impact. She proudly notes that Ireland is leading the way in diagnosing von Willebrand disease and bleeding disorders in women, thanks to the combined efforts of the National Coagulation Centre and the Irish Centre for Vascular Biology. The Low Von Willebrand in Ireland Cohort study, supported by the Health Research Board, stands as the world's largest dedicated study of patients with low von Willebrand factor. "Our findings in Ireland are changing practices internationally," she states, highlighting the global influence of Irish research.
And this is the part most people miss... Bleeding disorders are likely far more prevalent than commonly perceived. Symptoms like persistent low haemoglobin or iron levels, leading to fatigue and reduced energy, can be indicative of an underlying bleeding disorder. Many women mistakenly believe that heavy periods are simply a normal part of their menstrual cycle, unaware that they could be a sign of a treatable condition. The fact that other women in their family experience similar issues can further normalize the condition, delaying diagnosis and treatment.
To address this knowledge gap, Dr. Lavin and her team have developed a valuable resource: the website knowyourflow.ie. This platform provides comprehensive information about heavy menstrual bleeding, empowering women to recognize potential symptoms and seek appropriate medical advice.
So, when should you consider seeking professional help? If you experience excessively heavy periods, prolonged bleeding after surgery or dental procedures, or nosebleeds lasting longer than 15 minutes, it's crucial to consult a haematologist for specialized blood tests. Early diagnosis and intervention can significantly improve your quality of life and prevent potential complications.
Outside of her demanding professional life, Dr. Lavin cherishes her time with her family. Her and her husband's lives revolve around their three children's activities, from dance recitals to swimming competitions. She also enjoys baking and eagerly contributes her creations to local bake sales.
Dr. Lavin's dedication to research and patient care is truly inspiring. But does this focus on women's bleeding disorders overshadow the importance of diagnosing and treating these conditions in men? And what are the ethical considerations surrounding hormone-based therapies for managing bleeding disorders in women? These are complex questions that warrant further discussion. What are your thoughts? Share your opinions and experiences in the comments below!
